To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.
Viral Infectious Diseases
A Summary of ProSci’s Research on HIV
ProSci‘s roots lie in the research of Human Immunodefficiency Virus and working to develop a neutralizing vaccine against it. Below is an “abstract of abstracts” summarizing the research performed over the last several years that has built their business from
April 2016: The Antibody Update
This months ProSci news features a new study on broadly neutralizing antibodies long term treatment of HIV, where the first reported Zika Virus death in US territory occured, and a fully human polyclonal antibodies against Ebola-Z. Broadly Neutralizing Antibodies Prevent
Antibodies & Targets: An Introduction to SAMHD1
SAMHD1, or Sterile Alpha Motif and Histidine/Aspartate domain-containing protein 1, is a dimeric enzyme with phosphohydrolase and nuclease activity that functions as a blockade for virus replication in dendritic cells, monocytes, and macrophages. Its activity is regulated through phosphorylation of
Antibody Suppresses AIDS Virus
News from ProSci: Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood. An H9 T cell, blue, is shown infected with HIV, yellow. Researchers at
Does the Llama Hold the Key to HIV Vaccines?
Llamas make especially tiny antibodies that can neutralize 60 strains of HIV. Known for being sturdy and dependable animals, leave it to llamas to deliver some good news in the slow-going quest for an HIV vaccine. (learn more about ProSci’s